VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q73023435 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010735.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q73023435‏
035 ‎‡a (OCoLC)Q73023435‏
100 0 ‎‡a ডেভিড জি কক্স‏ ‎‡9 bn‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a David G. Cox‏ ‎‡c researcher on genetics of breast cancer at Imperial College‏ ‎‡9 en‏
400 0 ‎‡a David G. Cox‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A common 8q24 variant in prostate and breast cancer from a large nested case-control study‏
670 ‎‡a Author's A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).‏
670 ‎‡a Author's A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation‏
670 ‎‡a Author's A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer‏
670 ‎‡a Author's A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer‏
670 ‎‡a Author's A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus‏
670 ‎‡a Author's A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease‏
670 ‎‡a Author's A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1‏
670 ‎‡a Author's A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).‏
670 ‎‡a Author's A new era for treatment development in HER2-positive breast cancer‏
670 ‎‡a Author's A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study‏
670 ‎‡a Author's AACR Special Conference: SNPs, haplotypes, and cancer - applications in molecular epidemiology, Key Biscayne, Florida, USA, 13-17 September 2003‏
670 ‎‡a Author's Abstract LB-272: Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma‏
670 ‎‡a Author's Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques‏
670 ‎‡a Author's Active and passive cigarette smoking and breast cancer risk: Results from the EPIC cohort‏
670 ‎‡a Author's Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study‏
670 ‎‡a Author's Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures‏
670 ‎‡a Author's An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers‏
670 ‎‡a Author's Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes‏
670 ‎‡a Author's Association analysis identifies 65 new breast cancer risk loci.‏
670 ‎‡a Author's Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study‏
670 ‎‡a Author's Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma‏
670 ‎‡a Author's Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis‏
670 ‎‡a Author's ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity‏
670 ‎‡a Author's Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States‏
670 ‎‡a Author's Breast cancer susceptibility loci and mammographic density‏
670 ‎‡a Author's Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)‏
670 ‎‡a Author's Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study‏
670 ‎‡a Author's Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma‏
670 ‎‡a Author's Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers‏
670 ‎‡a Author's Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium‏
670 ‎‡a Author's Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort‏
670 ‎‡a Author's CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium‏
670 ‎‡a Author's CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).‏
670 ‎‡a Author's Determinants of folate and vitamin B12 plasma levels in the French E3N-EPIC cohort‏
670 ‎‡a Author's Dietary fat intake and development of specific breast cancer subtypes‏
670 ‎‡a Author's Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium‏
670 ‎‡a Author's Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study‏
670 ‎‡a Author's Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).‏
670 ‎‡a Author's Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).‏
670 ‎‡a Author's Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women‏
670 ‎‡a Author's Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk‏
670 ‎‡a Author's Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes‏
670 ‎‡a Author's Genome-wide association studies and the clinic: a focus on breast cancer‏
670 ‎‡a Author's Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma‏
670 ‎‡a Author's Genome-wide association study identifies novel breast cancer susceptibility loci‏
670 ‎‡a Author's Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women‏
670 ‎‡a Author's Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy‏
670 ‎‡a Author's Genome-wide association study of prostate cancer-specific survival‏
670 ‎‡a Author's GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients‏
670 ‎‡a Author's Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer‏
670 ‎‡a Author's Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies‏
670 ‎‡a Author's Haplotypes of the estrogen receptor beta gene and breast cancer risk‏
670 ‎‡a Author's Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics‏
670 ‎‡a Author's HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.‏
670 ‎‡a Author's Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer‏
670 ‎‡a Author's IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).‏
670 ‎‡a Author's Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population.‏
670 ‎‡a Author's Influence of multiple APOE genetic variants on cognitive function in a cohort of older men - results from the Normative Aging Study‏
670 ‎‡a Author's Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate‏
670 ‎‡a Author's Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.‏
670 ‎‡a Author's Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma‏
670 ‎‡a Author's Mannose-binding lectin 2 gene and risk of adult glioma‏
670 ‎‡a Author's Mitochondrial haplogroups modify the effect of black carbon on age-related cognitive impairment‏
670 ‎‡a Author's N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium‏
670 ‎‡a Author's Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.‏
670 ‎‡a Author's No association between BRCA2 N372H and breast cancer risk‏
670 ‎‡a Author's No association between GPX1 Pro198Leu and breast cancer risk‏
670 ‎‡a Author's Performance of common genetic variants in breast-cancer risk models‏
670 ‎‡a Author's Polymorphisms in the ICAM gene locus are not associated with breast cancer Risk‏
670 ‎‡a Author's Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer‏
670 ‎‡a Author's Polymorphisms of the AURKA‏
670 ‎‡a Author's Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States).‏
670 ‎‡a Author's Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women‏
670 ‎‡a Author's Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies‏
670 ‎‡a Author's PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).‏
670 ‎‡a Author's Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors‏
670 ‎‡a Author's Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma‏
670 ‎‡a Author's Study designs for genome-wide association studies‏
670 ‎‡a Author's T.I.M.S: TaqMan Information Management System, tools to organize data flow in a genotyping laboratory‏
670 ‎‡a Author's Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2‏
670 ‎‡a Author's TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study‏
670 ‎‡a Author's The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk‏
670 ‎‡a Author's The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk‏
670 ‎‡a Author's The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies.‏
670 ‎‡a Author's The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US Caucasian women‏
670 ‎‡a Author's The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes‏
670 ‎‡a Author's The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.‏
670 ‎‡a Author's The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.‏
670 ‎‡a Author's Therogenetics: transferring GWAS technology to the clinic‏
670 ‎‡a Author's Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium‏
912 ‎‡a commonvariantsofthebrca1wildtypeallelemodifytheriskofbreastcancerinbrca1mutationcarriers‏ ‎‡A Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers‏ ‎‡9 1‏
912 ‎‡a associationbetweentelomerelengthandriskofcancerandnonneoplasticdiseasesamendelianrandomizationstudy‏ ‎‡A Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study‏ ‎‡9 1‏
912 ‎‡a associationanalysisidentifies65newbreastcancerriskloci‏ ‎‡A Association analysis identifies 65 new breast cancer risk loci.‏ ‎‡9 1‏
912 ‎‡a originalphylogeneticapproachidentifiedmitochondrialhaplogroupt1a1asinverselyassociatedwithbreastcancerriskinbrca2mutationcarriers‏ ‎‡A An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers‏ ‎‡9 1‏
912 ‎‡a 5polymorphismsandbreastcancerriskresultsfromthebreastcancerassociationconsortium‏ ‎‡A Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium‏ ‎‡9 1‏
912 ‎‡a geneticallypredictedlongertelomerelengthisassociatedwithincreasedriskofbcelllymphomasubtypes‏ ‎‡A Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes‏ ‎‡9 1‏
912 ‎‡a genomewideassociationstudyidentifiesmultiplesusceptibilitylocifordiffuselargebcelllymphoma‏ ‎‡A Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma‏ ‎‡9 1‏
912 ‎‡a genomewideassociationstudyidentifiesnovelbreastcancersusceptibilityloci‏ ‎‡A Genome-wide association study identifies novel breast cancer susceptibility loci‏ ‎‡9 1‏
912 ‎‡a genomewideassociationstudyofprostatecancerspecificsurvival‏ ‎‡A Genome-wide association study of prostate cancer-specific survival‏ ‎‡9 1‏
912 ‎‡a heterogeneityofbreastcancerassociationswith5susceptibilitylocibyclinicalandpathologicalcharacteristics‏ ‎‡A Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics‏ ‎‡9 1‏
912 ‎‡a hlaclass1and2diversitycontributestotheetiologicheterogeneityofnonhodgkinlymphomasubtypes‏ ‎‡A HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.‏ ‎‡9 1‏
912 ‎‡a identificationof10variantsassociatedwithriskofestrogenreceptornegativebreastcancer‏ ‎‡A Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer‏ ‎‡9 1‏
912 ‎‡a lupusrelatedsinglenucleotidepolymorphismsandriskofdiffuselargebcelllymphoma‏ ‎‡A Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma‏ ‎‡9 1‏
912 ‎‡a newlydiscoveredbreastcancersusceptibilitylocion3p24and17q232‏ ‎‡A Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.‏ ‎‡9 1‏
912 ‎‡a metaanalysisofgenomewideassociationstudiestoidentifyprostatecancersusceptibilitylociassociatedwithaggressiveandnonaggressivedisease‏ ‎‡A A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease‏ ‎‡9 1‏
912 ‎‡a genomewideassociationmetaanalysisofcirculatingsexhormonebindingglobulinrevealsmultiplelociimplicatedinsexsteroidhormoneregulation‏ ‎‡A A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation‏ ‎‡9 1‏
912 ‎‡a associationsofobesityandcirculatinginsulinandglucosewithbreastcancerriskamendelianrandomizationanalysis‏ ‎‡A Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis‏ ‎‡9 1‏
919 ‎‡a atmhaplotypesandcellularresponsetodnadamageassociationwithbreastcancerriskandclinicalradiosensitivity‏ ‎‡A ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity‏ ‎‡9 1‏
919 ‎‡a breastcancersusceptibilitylociandmammographicdensity‏ ‎‡A Breast cancer susceptibility loci and mammographic density‏ ‎‡9 1‏
919 ‎‡a commongeneticvariantsinprostatecancerriskpredictionresultsfromthencibreastandprostatecancercohortconsortiumbpc3‏ ‎‡A Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)‏ ‎‡9 1‏
919 ‎‡a commongeneticvariationinigf1igfbp1andigfbp3inrelationtomammographicdensityacrosssectionalstudy‏ ‎‡A Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study‏ ‎‡9 1‏
919 ‎‡a commonvariantsneartardbpandegr2areassociatedwithsusceptibilitytoewingsarcoma‏ ‎‡A Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma‏ ‎‡9 1‏
919 ‎‡a comprehensiveanalysisofcommongeneticvariationin61genesrelatedtosteroidhormoneandinsulinlikegrowthfactor1metabolismandbreastcancerriskinthencibreastandprostatecancercohortconsortium‏ ‎‡A Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium‏ ‎‡9 1‏
919 ‎‡a constitutionalvariantsarenotassociatedwithher2positivebreastcancerresultsfromthesign Alpha reclinicalcohort‏ ‎‡A Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort‏ ‎‡9 1‏
919 ‎‡a cyp17geneticvariationandriskofbreastandprostatecancerfromthenationalcancerinstitutebreastandprostatecancercohortconsortium‏ ‎‡A CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium‏ ‎‡9 1‏
919 ‎‡a cyp17geneticvariationandriskofbreastandprostatecancerfromthenationalcancerinstitutebreastandprostatecancercohortconsortiumbpc3‏ ‎‡A CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).‏ ‎‡9 1‏
919 ‎‡a associationbetweentp53r249smutationandpolymorphismsintp53intron1inhepatocellularcarcinoma‏ ‎‡A Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma‏ ‎‡9 1‏
919 ‎‡a assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesign Alpha reprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes‏ ‎‡A Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes‏ ‎‡9 1‏
919 ‎‡a ageatcanceronsetingermlinetp53mutationcarriersassociationwithpolymorphismsinpredictedgquadruplexstructures‏ ‎‡A Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures‏ ‎‡9 1‏
919 ‎‡a adiposityhormonereplacementtherapyuseandbreastcancerriskbyageandhormonereceptorstatusalargeprospectivecohortstudy‏ ‎‡A Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study‏ ‎‡9 1‏
919 ‎‡a activeandpassivecigarettesmokingandbreastcancerriskresultsfromtheepiccohort‏ ‎‡A Active and passive cigarette smoking and breast cancer risk: Results from the EPIC cohort‏ ‎‡9 1‏
919 ‎‡a accountingforhaplotypeuncertaintyinmatchedassociationstudiesacomparisonofsimpleandflexibletechniques‏ ‎‡A Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques‏ ‎‡9 1‏
919 ‎‡a determinantsoffolateandvitaminb12plasmalevelsinthefrenche3nepiccohort‏ ‎‡A Determinants of folate and vitamin B12 plasma levels in the French E3N-EPIC cohort‏ ‎‡9 1‏
919 ‎‡a dietaryfatintakeanddevelopmentofspecificbreastcancersubtypes‏ ‎‡A Dietary fat intake and development of specific breast cancer subtypes‏ ‎‡9 1‏
919 ‎‡a gene10geneinteractionbetweenmnsodandgpx1andbreastcancerriskanestedcasecontrolstudy‏ ‎‡A Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study‏ ‎‡9 1‏
919 ‎‡a geneticpolymorphismsofthegnrh1andgnrhrgenesandriskofbreastcancerinthenationalcancerinstitutebreastandprostatecancercohortconsortiumbpc3‏ ‎‡A Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).‏ ‎‡9 1‏
919 ‎‡a geneticvariabilityofthemtorpathwayandprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic‏ ‎‡A Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).‏ ‎‡9 1‏
919 ‎‡a geneticvariationatthecyp19a1locuspredictscirculatingestrogenlevelsbutnotbreastcancerriskinpostmenopausalwomen‏ ‎‡A Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women‏ ‎‡9 1‏
919 ‎‡a geneticvariationindnarepairpathwaygenesandpremenopausalbreastcancerrisk‏ ‎‡A Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk‏ ‎‡9 1‏
919 ‎‡a genomewideassociationstudiesandtheclinicafocusonbreastcancer‏ ‎‡A Genome-wide association studies and the clinic: a focus on breast cancer‏ ‎‡9 1‏
919 ‎‡a genomewideassociationstudyofcirculatingestradioltestosteroneandsexhormonebindingglobulininpostmenopausalwomen‏ ‎‡A Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women‏ ‎‡9 1‏
919 ‎‡a genomewideassociationstudyofeventfreesurvivalindiffuselargebcelllymphomatreatedwithimmunochemotherapy‏ ‎‡A Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy‏ ‎‡9 1‏
919 ‎‡a gwasinthesign Alpha reclinicalcohortrestrictstheassociationbetweenthefgfr2locusandestrogenreceptorstatustoher2negativebreastcancerpatients‏ ‎‡A GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients‏ ‎‡9 1‏
919 ‎‡a haplotypeanalysisofcommonvariantsinthebrca1geneandriskofsporadicbreastcancer‏ ‎‡A Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer‏ ‎‡9 1‏
919 ‎‡a haplotypeanalysisofthehsd17b1geneandriskofbreastcanceracomprehensiveapproachtomulticenteranalysesofprospectivecohortstudies‏ ‎‡A Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies‏ ‎‡9 1‏
919 ‎‡a haplotypesoftheestrogenreceptorbetageneandbreastcancerrisk‏ ‎‡A Haplotypes of the estrogen receptor beta gene and breast cancer risk‏ ‎‡9 1‏
919 ‎‡a igf1igfbp1andigfbp3polymorphismspredictcirculatingigflevelsbutnotbreastcancerriskfindingsfromthebreastandprostatecancercohortconsortiumbpc3‏ ‎‡A IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).‏ ‎‡9 1‏
919 ‎‡a impactofbodymassindexageprostatevolumeandgeneticpolymorphismsonprostatespecificantigenlevelsinacontrolpopulation‏ ‎‡A Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population.‏ ‎‡9 1‏
919 ‎‡a influenceofmultipleapoegeneticvariantsoncognitivefunctioninacohortofoldermenresultsfromthenormativeagingstudy‏ ‎‡A Influence of multiple APOE genetic variants on cognitive function in a cohort of older men - results from the Normative Aging Study‏ ‎‡9 1‏
919 ‎‡a abstractlb272genomewideassociationstudyidentifiesmultiplesusceptibilitylocifordiffuselargebcelllymphoma‏ ‎‡A Abstract LB-272: Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma‏ ‎‡9 1‏
919 ‎‡a largescaleevaluationofgeneticvariantsincandidategenesforcolorectalcancerriskinthenurseshealthstudyandthehealthprofessionalsfollowupstudy‏ ‎‡A Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.‏ ‎‡9 1‏
919 ‎‡a mannosebindinglectin2geneandriskofadultglioma‏ ‎‡A Mannose-binding lectin 2 gene and risk of adult glioma‏ ‎‡9 1‏
919 ‎‡a mitochondrialhaplogroupsmodifytheeffectofblackcarbononagerelatedcognitiveimpairment‏ ‎‡A Mitochondrial haplogroups modify the effect of black carbon on age-related cognitive impairment‏ ‎‡9 1‏
919 ‎‡a nacetyltransferase2polymorphismstobaccosmokingandbreastcancerriskinthebreastandprostatecancercohortconsortium‏ ‎‡A N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium‏ ‎‡9 1‏
919 ‎‡a noassociationbetweenbrca2n372handbreastcancerrisk‏ ‎‡A No association between BRCA2 N372H and breast cancer risk‏ ‎‡9 1‏
919 ‎‡a noassociationbetweengpx1pro198leuandbreastcancerrisk‏ ‎‡A No association between GPX1 Pro198Leu and breast cancer risk‏ ‎‡9 1‏
919 ‎‡a performanceofcommongeneticvariantsinbreastcancerriskmodels‏ ‎‡A Performance of common genetic variants in breast-cancer risk models‏ ‎‡9 1‏
919 ‎‡a polymorphismsintheicamgenelocusarenotassociatedwithbreastcancerrisk‏ ‎‡A Polymorphisms in the ICAM gene locus are not associated with breast cancer Risk‏ ‎‡9 1‏
919 ‎‡a polymorphismsinxenobioticmetabolizinggenesintakesofheterocyclicaminesandredmeatandpostmenopausalbreastcancer‏ ‎‡A Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer‏ ‎‡9 1‏
919 ‎‡a polymorphismsoftheaurka‏ ‎‡A Polymorphisms of the AURKA‏ ‎‡9 1‏
919 ‎‡a polymorphismsoftheaurkastk15aurorakinasegeneandbreastcancerriskunitedstates‏ ‎‡A Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States).‏ ‎‡9 1‏
919 ‎‡a postgwasgeneenvironmentinterplayinbreastcancerresultsfromthebreastandprostatecancercohortconsortiumandametaanalysison79000women‏ ‎‡A Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women‏ ‎‡9 1‏
919 ‎‡a prediagnosticplasmaigelevelsandriskofadultgliomain4prospectivecohortstudies‏ ‎‡A Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies‏ ‎‡9 1‏
919 ‎‡a ptgs2andil6geneticvariationandriskofbreastandprostatecancerresultsfromthebreastandprostatecancercohortconsortiumbpc3‏ ‎‡A PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsystempolymorphismsandriskofhypertensioninfluenceofenvironmentalfactors‏ ‎‡A Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors‏ ‎‡9 1‏
919 ‎‡a singlenucleotidepolymorphismsofallergyrelatedgenesandriskofadultglioma‏ ‎‡A Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma‏ ‎‡9 1‏
919 ‎‡a studydesignsforgenomewideassociationstudies‏ ‎‡A Study designs for genome-wide association studies‏ ‎‡9 1‏
919 ‎‡a t11000staqmaninformationmanagementsystemtoolstoorganizedataflowinagenotypinglaboratory‏ ‎‡A T.I.M.S: TaqMan Information Management System, tools to organize data flow in a genotyping laboratory‏ ‎‡9 1‏
919 ‎‡a targetedsequencingofthemitochondrialgenomeofwomenathighriskofbreastcancerwithoutdetectablemutationsinbrca12‏ ‎‡A Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2‏ ‎‡9 1‏
919 ‎‡a tgfb1andtgfbr1polymorphismsandbreastcancerriskinthenurseshealthstudy‏ ‎‡A TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study‏ ‎‡9 1‏
919 ‎‡a erbb2her2neureceptorpolymorphismile655valandbreastcancerrisk‏ ‎‡A The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk‏ ‎‡9 1‏
919 ‎‡a mitochondriala10398gpolymorphisminteractionwithalcoholconsumptionandbreastcancerrisk‏ ‎‡A The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk‏ ‎‡9 1‏
919 ‎‡a p53arg72proandmdm2309polymorphismsandriskofbreastcancerinthenurseshealthstudies‏ ‎‡A The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies.‏ ‎‡9 1‏
919 ‎‡a p53codon72polymorphismsunburnsandriskofskincancerinuscaucasianwomen‏ ‎‡A The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US Caucasian women‏ ‎‡9 1‏
919 ‎‡a roleofmicrornabindingsitepolymorphismsindnarepairgenesasriskfactorsforbladdercancerandbreastcancerandtheirimpactonradiotherapyoutcomes‏ ‎‡A The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes‏ ‎‡9 1‏
919 ‎‡a rs2910164g100snpinthemir146ageneisnotassociatedwithbreastcancerriskinbrca1andbrca2mutationcarriers‏ ‎‡A The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.‏ ‎‡9 1‏
919 ‎‡a xrcc177t100varianthaplotypesbreastcancerriskresponsetoradiotherapyandthecellularresponsetodnadamage‏ ‎‡A The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.‏ ‎‡9 1‏
919 ‎‡a therogeneticstransferringgwastechnologytotheclinic‏ ‎‡A Therogenetics: transferring GWAS technology to the clinic‏ ‎‡9 1‏
919 ‎‡a vitamin500receptorpolymorphismsandbreastcancerriskresultsfromthenationalcancerinstitutebreastandprostatecancercohortconsortium‏ ‎‡A Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium‏ ‎‡9 1‏
919 ‎‡a breastcancerriskfrommodifiableandnonmodifiableriskfactorsamongwhitewomenintheunitedstates‏ ‎‡A Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States‏ ‎‡9 1‏
919 ‎‡a aacrspecialconferencesnpshaplotypesandcancerapplicationsinmolecularepidemiologykeybiscaynefloridausa1317september‏ ‎‡A AACR Special Conference: SNPs, haplotypes, and cancer - applications in molecular epidemiology, Key Biscayne, Florida, USA, 13-17 September 2003‏ ‎‡9 1‏
919 ‎‡a polymorphisminthe3untranslatedregionofthegeneencodingprostaglandinendoperoxidesynthase2isnotassociatedwithanincreaseinbreastcancerriskanestedcasecontrolstudy‏ ‎‡A A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study‏ ‎‡9 1‏
919 ‎‡a newerafortreatmentdevelopmentinher2positivebreastcancer‏ ‎‡A A new era for treatment development in HER2-positive breast cancer‏ ‎‡9 1‏
919 ‎‡a multistagegenomewideassociationstudyinbreastcanceridentifies2newriskallelesat1p112and14q241rad51l1‏ ‎‡A A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).‏ ‎‡9 1‏
919 ‎‡a multistagegenomewideassociationstudyinbreastcanceridentifies2newriskallelesat1p112and14q241‏ ‎‡A A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1‏ ‎‡9 1‏
919 ‎‡a gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus‏ ‎‡A A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus‏ ‎‡9 1‏
919 ‎‡a genomewidepleiotropyscandoesnotidentifynewsusceptibilitylociforestrogenreceptornegativebreastcancer‏ ‎‡A A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer‏ ‎‡9 1‏
919 ‎‡a genomewideassociationstudyidentifiesallelesinfgfr2associatedwithriskofsporadicpostmenopausalbreastcancer‏ ‎‡A A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer‏ ‎‡9 1‏
919 ‎‡a comprehensiveanalysisoftheandrogenreceptorgeneandriskofbreastcancerresultsfromthenationalcancerinstitutebreastandprostatecancercohortconsortiumbpc3‏ ‎‡A A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).‏ ‎‡9 1‏
919 ‎‡a common8q24variantinprostateandbreastcancerfromalargenestedcasecontrolstudy‏ ‎‡A A common 8q24 variant in prostate and breast cancer from a large nested case-control study‏ ‎‡9 1‏
919 ‎‡a interactionsbetweengenomewidesignificantgeneticvariantsandcirculatingconcentrationsofinsulinlikegrowthfactor1sexhormonesandbindingproteinsinrelationtoprostatecancerriskinthenationalcancerinstitutebreastandprostate‏ ‎‡A Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate‏ ‎‡9 1‏
943 ‎‡a 200x‏ ‎‡A 2003‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000118397956‏
996 ‎‡2 LC|no 93001720‏
996 ‎‡2 LC|n 97069973‏
996 ‎‡2 ISNI|0000000110639383‏
996 ‎‡2 ISNI|0000000067060359‏
996 ‎‡2 ISNI|0000000050795690‏
996 ‎‡2 RERO|A009117576‏
996 ‎‡2 SUDOC|188240772‏
996 ‎‡2 LC|n 86833183‏
996 ‎‡2 NTA|069525706‏
996 ‎‡2 SUDOC|076926184‏
996 ‎‡2 DNB|1050205499‏
996 ‎‡2 ISNI|0000000118180984‏
996 ‎‡2 NLR|RU NLR AUTH 77117370‏
996 ‎‡2 NUKAT|n 96301576‏
996 ‎‡2 CAOONL|ncf11904054‏
996 ‎‡2 BIBSYS|12014290‏
996 ‎‡2 CAOONL|ncf10168186‏
996 ‎‡2 LC|nr 91027604‏
996 ‎‡2 LC|no2020029251‏
996 ‎‡2 CAOONL|ncf10373866‏
996 ‎‡2 LC|nr 91027600‏
996 ‎‡2 NTA|329129589‏
996 ‎‡2 NSK|000727974‏
996 ‎‡2 PLWABN|9810660585405606‏
996 ‎‡2 CAOONL|ncf10155613‏
996 ‎‡2 BIBSYS|10051821‏
996 ‎‡2 BNF|13985102‏
996 ‎‡2 ISNI|0000000080166799‏
996 ‎‡2 BNF|13574361‏
996 ‎‡2 NKC|ntk20211104861‏
996 ‎‡2 DNB|1265599238‏
996 ‎‡2 LC|nb2011008814‏
996 ‎‡2 LC|n 87944827‏
996 ‎‡2 ISNI|0000000074090951‏
996 ‎‡2 LC|n 96036045‏
996 ‎‡2 ISNI|0000000080153592‏
996 ‎‡2 LC|n 88167261‏
996 ‎‡2 NTA|306026481‏
996 ‎‡2 BNF|15047212‏
996 ‎‡2 LC|n 79142927‏
996 ‎‡2 ISNI|0000000118568276‏
996 ‎‡2 SUDOC|181016915‏
996 ‎‡2 LC|n 83154900‏
996 ‎‡2 LC|nr2006022979‏
996 ‎‡2 NUKAT|n 2009050430‏
996 ‎‡2 NLA|000036085559‏
996 ‎‡2 LC|n 2004097096‏
996 ‎‡2 NTA|331559072‏
996 ‎‡2 ISNI|000000039929520X‏
996 ‎‡2 SUDOC|132365111‏
996 ‎‡2 LC|no2003082877‏
996 ‎‡2 DNB|1275313507‏
996 ‎‡2 ISNI|0000000080854356‏
996 ‎‡2 ISNI|0000000507202657‏
996 ‎‡2 LC|nb2015008148‏
996 ‎‡2 ISNI|0000000084592138‏
996 ‎‡2 LC|n 87871327‏
996 ‎‡2 DNB|1084589869‏
996 ‎‡2 ISNI|0000000114718839‏
996 ‎‡2 ISNI|0000000117039305‏
996 ‎‡2 SUDOC|190548193‏
996 ‎‡2 NLA|000035219427‏
996 ‎‡2 ISNI|0000000042053267‏
996 ‎‡2 SUDOC|122675533‏
996 ‎‡2 RERO|A003141513‏
996 ‎‡2 ISNI|0000000073821900‏
996 ‎‡2 RERO|A003141516‏
996 ‎‡2 RERO|A003141514‏
996 ‎‡2 ISNI|000000003239528X‏
996 ‎‡2 BIBSYS|68501‏
996 ‎‡2 PLWABN|9810662847205606‏
996 ‎‡2 DNB|1095518186‏
996 ‎‡2 LC|no2015116974‏
996 ‎‡2 J9U|987007431841205171‏
996 ‎‡2 LC|nb2001032937‏
996 ‎‡2 NII|DA09862240‏
996 ‎‡2 LC|n 88222003‏
996 ‎‡2 LC|no2008121882‏
996 ‎‡2 DNB|1206941332‏
996 ‎‡2 ISNI|0000000373911510‏
996 ‎‡2 SUDOC|251343790‏
996 ‎‡2 LNB|LNC10-000138312‏
996 ‎‡2 J9U|987007275476405171‏
996 ‎‡2 NII|DA13725549‏
996 ‎‡2 LC|n 2012049480‏
996 ‎‡2 PLWABN|9810665146205606‏
996 ‎‡2 NLA|000036521808‏
996 ‎‡2 NUKAT|n 97086181‏
996 ‎‡2 RERO|A013389133‏
996 ‎‡2 BNF|16937152‏
996 ‎‡2 LC|nb2016004729‏
996 ‎‡2 CAOONL|ncf10092039‏
996 ‎‡2 J9U|987007461232805171‏
996 ‎‡2 LC|n 94118012‏
996 ‎‡2 BNF|17045598‏
996 ‎‡2 CAOONL|ncf10668728‏
996 ‎‡2 LC|no2012024536‏
996 ‎‡2 LC|n 50018783‏
996 ‎‡2 J9U|987007388938005171‏
996 ‎‡2 DNB|174196989‏
996 ‎‡2 ISNI|0000000074073342‏
996 ‎‡2 ISNI|000000043986560X‏
996 ‎‡2 BNF|12254787‏
996 ‎‡2 NUKAT|n 02091018‏
996 ‎‡2 BIBSYS|90115300‏
996 ‎‡2 BIBSYS|8019327‏
996 ‎‡2 PLWABN|9810649814505606‏
996 ‎‡2 DNB|1080370323‏
996 ‎‡2 DNB|1020694130‏
996 ‎‡2 J9U|987007516710705171‏
996 ‎‡2 SUDOC|166980803‏
996 ‎‡2 NTA|074473123‏
996 ‎‡2 SUDOC|031763839‏
996 ‎‡2 ISNI|0000000378063354‏
996 ‎‡2 SUDOC|095251987‏
996 ‎‡2 DNB|132824892‏
996 ‎‡2 LC|n 92097875‏
996 ‎‡2 ISNI|0000000024291923‏
996 ‎‡2 DNB|173814654‏
996 ‎‡2 DNB|1186656123‏
996 ‎‡2 BNF|14453817‏
996 ‎‡2 NYNYRILM|10470‏
996 ‎‡2 CAOONL|ncf10505350‏
996 ‎‡2 LC|n 86828123‏
996 ‎‡2 SUDOC|069865000‏
996 ‎‡2 RERO|A023649745‏
996 ‎‡2 NII|DA07287866‏
996 ‎‡2 NUKAT|n 2019164581‏
996 ‎‡2 SUDOC|236894285‏
996 ‎‡2 DNB|1020064617‏
996 ‎‡2 ISNI|0000000083492768‏
996 ‎‡2 BNC|981058519138206706‏
996 ‎‡2 CAOONL|ncf11912549‏
996 ‎‡2 SIMACOB|24848995‏
996 ‎‡2 LNB|LNC10-000025939‏
996 ‎‡2 SUDOC|154389935‏
996 ‎‡2 ISNI|0000000067175922‏
996 ‎‡2 BIBSYS|5045916‏
996 ‎‡2 ISNI|0000000038399599‏
996 ‎‡2 LC|no2006117543‏
996 ‎‡2 ISNI|0000000374071074‏
996 ‎‡2 ISNI|0000000418887295‏
996 ‎‡2 ISNI|0000000120416052‏
996 ‎‡2 SUDOC|170548015‏
996 ‎‡2 NUKAT|n 2011076722‏
996 ‎‡2 LC|n 92047101‏
996 ‎‡2 DBC|87097968226066‏
996 ‎‡2 ISNI|0000000067791290‏
996 ‎‡2 LC|nb2011008828‏
996 ‎‡2 LC|nb2013018970‏
996 ‎‡2 LC|nb2011008821‏
996 ‎‡2 B2Q|0000809453‏
996 ‎‡2 LC|n 2012050492‏
996 ‎‡2 LC|nb2011008824‏
996 ‎‡2 JPG|500115416‏
996 ‎‡2 LIH|LNB:_v_PE;=B_h_‏
996 ‎‡2 NTA|071146350‏
996 ‎‡2 ISNI|000000037952997X‏
996 ‎‡2 CAOONL|ncf10731366‏
996 ‎‡2 ISNI|0000000365795775‏
996 ‎‡2 NUKAT|n 2021020855‏
996 ‎‡2 NII|DA03889131‏
996 ‎‡2 N6I|vtls000011323‏
996 ‎‡2 NTA|395170060‏
996 ‎‡2 LC|n 86815499‏
996 ‎‡2 SELIBR|182371‏
996 ‎‡2 CAOONL|ncf10158472‏
996 ‎‡2 ISNI|000000002178604X‏
996 ‎‡2 JPG|500009210‏
996 ‎‡2 NLA|000036200246‏
996 ‎‡2 J9U|987007522984805171‏
996 ‎‡2 NLA|000035376318‏
996 ‎‡2 SUDOC|152671218‏
996 ‎‡2 ISNI|0000000001112953‏
996 ‎‡2 CAOONL|ncf11490917‏
996 ‎‡2 LC|n 99802231‏
996 ‎‡2 BNC|981058512316306706‏
996 ‎‡2 LC|n 86804593‏
996 ‎‡2 LIH|LNB:H__K;=_w_C‏
996 ‎‡2 ISNI|0000000044509838‏
996 ‎‡2 BIBSYS|3025551‏
996 ‎‡2 ISNI|0000000001215274‏
996 ‎‡2 ISNI|0000000388804400‏
996 ‎‡2 SELIBR|182358‏
996 ‎‡2 J9U|987007438819605171‏
996 ‎‡2 LC|n 78047532‏
996 ‎‡2 ISNI|0000000050650301‏
996 ‎‡2 LC|no2003125962‏
996 ‎‡2 ISNI|0000000109288336‏
996 ‎‡2 B2Q|0001565520‏
996 ‎‡2 LC|no2005119508‏
996 ‎‡2 LC|no2018174206‏
996 ‎‡2 J9U|987007279367405171‏
996 ‎‡2 CAOONL|ncf11203895‏
996 ‎‡2 ISNI|000000045220999X‏
996 ‎‡2 NTA|132327988‏
996 ‎‡2 J9U|987007322124505171‏
996 ‎‡2 LC|n 97109446‏
996 ‎‡2 NLA|000035031781‏
996 ‎‡2 NLA|000035031783‏
996 ‎‡2 DNB|122229026X‏
996 ‎‡2 LC|nb2011008678‏
996 ‎‡2 ISNI|0000000116587967‏
996 ‎‡2 LC|nb2007017963‏
996 ‎‡2 ICCU|CUBV027870‏
996 ‎‡2 LC|nb2018019566‏
996 ‎‡2 NTA|194963977‏
996 ‎‡2 CAOONL|ncf10646271‏
996 ‎‡2 NTA|069208166‏
996 ‎‡2 DNB|1255807520‏
996 ‎‡2 DNB|1226030815‏
996 ‎‡2 NLA|000035584514‏
996 ‎‡2 NLA|000036520086‏
996 ‎‡2 CAOONL|ncf10471721‏
996 ‎‡2 LC|n 78018940‏
996 ‎‡2 DNB|1142164721‏
996 ‎‡2 LC|no 92003561‏
996 ‎‡2 CAOONL|ncf11578799‏
996 ‎‡2 DNB|170392503‏
996 ‎‡2 LC|nr 89017477‏
996 ‎‡2 BIBSYS|4068481‏
996 ‎‡2 NKC|xx0156175‏
996 ‎‡2 DNB|1203395469‏
996 ‎‡2 N6I|vtls001288452‏
996 ‎‡2 RERO|A022771062‏
996 ‎‡2 NII|DA00870374‏
996 ‎‡2 N6I|vtls001390888‏
996 ‎‡2 LC|nb2014025393‏
996 ‎‡2 NTA|194963470‏
996 ‎‡2 LC|no2011003708‏
996 ‎‡2 NTA|07146283X‏
996 ‎‡2 NLA|000049861888‏
996 ‎‡2 SELIBR|182915‏
996 ‎‡2 DNB|10245826X‏
996 ‎‡2 J9U|987007463071005171‏
996 ‎‡2 ISNI|0000000382045060‏
996 ‎‡2 BNF|13600156‏
996 ‎‡2 LNB|LNC10-000153448‏
996 ‎‡2 DNB|129924830‏
996 ‎‡2 LC|nr 96039999‏
996 ‎‡2 BIBSYS|99052609‏
996 ‎‡2 ISNI|000000041020113X‏
996 ‎‡2 ERRR|a11996328‏
996 ‎‡2 ISNI|0000000043668749‏
996 ‎‡2 ISNI|0000000118606914‏
996 ‎‡2 LC|no2019154592‏
996 ‎‡2 CAOONL|ncf12098434‏
996 ‎‡2 LC|nb 99038180‏
996 ‎‡2 NLA|000036232050‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏